Post-transplant cyclophosphamide and bortezomib inhibit dendritic cell maturation and function and alter their IκB and NFκB-Reference-Cited by-同舟云学术

Post-transplant cyclophosphamide and bortezomib inhibit dendritic cell maturation and function and alter their IκB and NFκB

Published:2014-01 Issue:1 Volume:30 Page:40-45
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Al-Homsi Ahmad Samer,Lai Zhongbin^ORCID,Roy Tara S.,Al-Malki M. Monzr,Kouttab Nicholas,Junghans Richard P.

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference32 articles.

1. Edward Donnall Thomas

2. Obituary;Watts;Lancet,2011

3. Hematopoietic cell transplantation at 50;Appelbaum;N Engl J Med,2007

4. US Department of Health and Human Services; Health Resources and Service Administration. http://bloodcell.transplant.hrsa.gov/about/general_faqs/index.html.

5. Immunobiology of allogeneic hematopoietic stem cell transplantation;Welniak;Annu Rev Immunol,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Advanced Glycation End Products and Their Soluble Receptor as New Biomarkers in Systemic Lupus Erythematosus;Biomedicines;2024-03-07

2. Inflammation, NF-κB, and Chronic Diseases: How are They Linked?;Critical Reviews in Immunology;2020

3. Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding;Frontiers in Immunology;2019-11-29

4. Targeting IκappaB kinases for cancer therapy;Seminars in Cancer Biology;2019-06

5. Bortezomib for the prevention and treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation;Experimental Hematology;2016-09